FDA mulls compounding for peptides previously flagged over safety risks BioSpace When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law FDA Compliance for Peptide Therapy and BPC 157 Holt Law More Americans are injecting themselves with peptides BPC 157: Experimental Peptide Creates Risk for Athletes